Melhores Terapia de Radiação para Sarcomas médicos em Israel - TOP-4 médicos

O Prof. Merimsky lidera a Unidade de Oncologia de Tecidos Moles e Ósseos no Sourasky Medical Center – um pioneiro no tratamento de sarcoma com mais de 25 anos de experiência especializada.

• Realizou um fellowship no Institut Gustave Roussy em Paris – o centro de sarcoma líder na Europa
• Membro do Corpo Docente da ESMO para sarcoma – ajuda a moldar as diretrizes internacionais de tratamento
• Publicou extensivamente sobre terapias e resultados de sarcoma
• Combina a oncologia por radiação com abordagens de tratamento sistêmicas

O Dr. Dror Levin é especialista no tratamento de sarcoma pediátrico no Centro Médico Sourasky – um dos principais hospitais de Israel para cânceres infantis.

• Diretor de hematologia e oncologia pediátrica no Sourasky
• Formação no Instituto Ortopédico Rizzoli – um líder mundial no tratamento de sarcoma
• Coordena o tratamento de sarcoma com equipes de oncologia ortopédica
• Membro da associação israelense de hemato-oncologia pediátrica (ISPHO)

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Dr. Eytan Aharon Ben‑Ami, MD, is a Senior Physician in the Sarcoma and Bone Oncology Service at Sheba Medical Center. He heads the Oncology Division and the Early-Phase Clinical Trials Unit. He founded the Sheba Clinical Research Organization. He is an academic affiliate at Tel Aviv University.

He specializes in sarcomas and primary bone tumors, including soft tissue sarcoma, liposarcoma, leiomyosarcoma, and osteosarcoma. He leads Phase I trials in targeted therapy and immunotherapy. He designs personalized treatment plans for rare cancers. He also develops patient-centered programs, including pilots in advanced immunotherapy delivery.

He completed a fellowship in Sarcoma and Bone Oncology at the Dana-Farber Cancer Institute/Harvard Cancer Center. He has authored more than 40 publications on early detection, molecular and viral mechanisms, and new cancer therapies.